First Time Loading...

OPKO Health Inc
NASDAQ:OPK

Watchlist Manager
OPKO Health Inc Logo
OPKO Health Inc
NASDAQ:OPK
Watchlist
Price: 1.3 USD Market Closed
Updated: May 5, 2024

OPKO Health Inc
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

OPKO Health Inc
Revenue Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
OPKO Health Inc
NASDAQ:OPK
Revenue
$863.5m
CAGR 3-Years
-16%
CAGR 5-Years
-3%
CAGR 10-Years
25%
Abbvie Inc
NYSE:ABBV
Revenue
$54.3B
CAGR 3-Years
6%
CAGR 5-Years
11%
CAGR 10-Years
11%
Gilead Sciences Inc
NASDAQ:GILD
Revenue
$27.5B
CAGR 3-Years
2%
CAGR 5-Years
4%
CAGR 10-Years
7%
Amgen Inc
NASDAQ:AMGN
Revenue
$28.2B
CAGR 3-Years
4%
CAGR 5-Years
3%
CAGR 10-Years
4%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Revenue
$9.9B
CAGR 3-Years
17%
CAGR 5-Years
26%
CAGR 10-Years
23%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Revenue
$13.1B
CAGR 3-Years
16%
CAGR 5-Years
14%
CAGR 10-Years
20%

OPKO Health Inc
Revenue Breakdown

Breakdown by Geography
OPKO Health Inc

Total Revenue: 863.5m USD
100%
United States: 597.8m USD
69.2%
Ireland: 141.5m USD
16.4%
Chile: 68.5m USD
7.9%
Spain: 23.5m USD
2.7%
Mexico: 20.2m USD
2.3%
Israel: 9.7m USD
1.1%
Other Countries: 2.2m USD
0.3%
Show More
Show Less

Breakdown by Segments
OPKO Health Inc

Total Revenue: 863.5m USD
100%
Service: 515.3m USD
59.7%
Transfer Of Intellectual Property And Other: 180.7m USD
20.9%
Product: 167.6m USD
19.4%
Rayaldee: 67.5m USD
7.8%
Show More
Show Less

See Also

What is OPKO Health Inc's Revenue?
Revenue
863.5m USD

Based on the financial report for Dec 31, 2023, OPKO Health Inc's Revenue amounts to 863.5m USD.

What is OPKO Health Inc's Revenue growth rate?
Revenue CAGR 10Y
25%

Over the last year, the Revenue growth was -14%. The average annual Revenue growth rates for OPKO Health Inc have been -16% over the past three years , -3% over the past five years , and 25% over the past ten years .